Repligen Corporation delivered a sharp 11% single-day rally on July 28, flipping the script on a short book that had spent weeks rebuilding ahead of the print.
The previous note flagged exactly this risk: short interest had climbed to nearly 11% of the free float and days-to-cover sat near 4.6, meaning a strong earnings reaction would force fast covering. That is precisely what happened. Short interest has now edged back to 10.9% of the float — down roughly 0.7% on the day and 0.3% over the week — a modest unwind relative to the move, suggesting shorts have not yet fully capitulated. The borrow market reflects the tension: availability tightened from around 353% a week ago to 298% today, still well within normal territory but the sharpest weekly contraction in the past month. Cost to borrow, while still low at 0.57%, has risen about 10% over the week — a small but directional signal that demand for borrows picked up alongside the rally.
The options market was flashing the loudest warning of any coming move. The put/call ratio jumped to 2.68 on July 28, nearly four standard deviations above its 20-day average of 1.83 — a reading that points to extreme defensive hedging right at the earnings date. That spike has almost certainly unwound as the results came in. The stock's only comparable recent post-earnings data point is the May 14 print, where RGEN fell 3.9% on the day before recovering 5.9% over the following week — a pattern suggesting earnings volatility that fades quickly once the dust settles.
The Street is largely on board with the recovery thesis but has been selectively adjusting targets. JP Morgan raised its target to $175 from $165 today, maintaining Overweight — the clearest vote of confidence from a major firm immediately post-results. Earlier in July, Benchmark upgraded to Buy with a $185 target, and Evercore lifted its Outperform target to $160 from $150. The consensus mean now sits at $185, roughly 27% above Tuesday's close of $145.34. That gap explains the constructive tone: with the stock still down about 1% over the past month despite this week's 6% gain, most of the Street sees meaningful re-rating room if execution holds. The EV/EBITDA multiple, running near 41.8x, has expanded about 3.3 turns over the week — a sign the market is beginning to price in more of that recovery, though it remains well below the stretched valuations of the sector's peak years. Analyst recommendation differentiation ranks in the 93rd percentile of the universe, reflecting unusually wide divergence between bulls and more cautious holders.
Institutional ownership adds context to why the short book faces a structural ceiling. T. Rowe Price holds 11.1% of shares and added nearly one million shares in the quarter to June 30. BlackRock added a further 241,000 shares in the same period. Wasatch Advisors, a specialist in smaller growth names, added 499,000 shares. That is three active buyers of size absorbing supply simultaneously — a backdrop that limits how aggressively shorts can rebuild without fighting concentrated long-side conviction.
The next scheduled event is the earnings call at 16:30 UTC on July 30, one trading day away, where the detail behind the top-line numbers will be the focus — particularly whether the margin guidance compression flagged in the bear case (adjusted operating margins near 13.5%) was revised, and whether the over-50% Process Analytics revenue growth cited in the bull case is sustainable or a one-period anomaly.
See the live data behind this article on ORTEX.
Open RGEN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
